US EditionMediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns - MediPharm Labs (OTC:MEDIF)
- Shelley Potts has stepped down from the Board of MediPharm Labs, according to the announcement.
- Michael Bumby is returning to the Board of MediPharm Labs, according to the announcement.
- The news release includes forward-looking statements regarding the company's future actions and performance.
- Readers are warned not to place undue reliance on these forward-looking statements, which may differ from actual results.
11 Articles
11 Articles
MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns - MediPharm Labs (OTC:MEDIF)
TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today announced that Shelley Potts will be stepping down from the Company's Board of Directors (the "Board"), effective December 31, 2025. The Company also announced that Michael Bumby will be rejoining the Board, effective January 1, 2026, bringi…
Potts Out, Bumby in on MediPharm Labs Board
TORONTO — MediPharm Labs Corp. board of directors member Shelley Potts will be stepping down effective December 31, 2025. Michael Bumby will replace her effective January 1, 2026. Bumby previously served on the Board and was Chief Financial Officer at VIVO Cannabis Inc., which MediPharm acquired in 2023. In addition to his experience in the cannabis sector, he has held senior leadership roles in global pharmaceutical companies, providing strateg…
Coverage Details
Bias Distribution
- 56% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
